Primary study · included by 2 reviews

Clark 2018

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Use of cells and/or biologics combined with scaffolds in alveolar bone augmentation for implant site development.

Non-Cochrane · intervention · 2026 · cited as Clark 2018 · Forest plot Figure 3 or 4; Supplement Table 1

Outcome this study informs	Pooled effect	Evidence	Certainty
Mineralized tissue (%) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 7.46 [-10.94, 25.86]	5 studies	GRADE not reported
Ridge height change (mm) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 0.40 [0.16, 0.63]	6 studies	GRADE not reported
Ridge width change (mm) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 0.48 [0.03, 0.93]	7 studies	GRADE not reported
Residual graft (%) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD -5.01 [-12.19, 2.17]	5 studies	GRADE not reported

Component network meta-analysis of scaffold materials, platelet-rich fibrin and barrier membranes for alveolar ridge preservation.

Non-Cochrane · intervention · 2026 · cited as Clark 2018 · Table 1; reference 27

The review does not say which of its outcomes this study informs.

2 including reviews in total.